history of glp-1 drugs Market Overview: Agonists and the Obesity Market | Blog What are GLP-1s? | Mendinground
Description
Victoza (liraglutide) Approved uses: Adults and children over 10 with type 2 diabetes, and adults with type 2 diabetes and heart disease Drug type: Once-daily injection Doses: 0.6 mg (initial dose), 1.2 mg, and 1.8 mg Cost: Victoza is covered by most health plans, including Medicare and Medicaid

Questions remain about the safety of these drugs with regard to the risk of pancreatitis and the development of MTC in patients receiving liraglutide

2013 Nov;37(11):1514

Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study

Choi IY, Lee JS, Kim JK, Lee SH, Kim YH, Park YJ, et al

Additional information Publishers Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
